Dr. Lal PathLabs Limited
LALPATHLAB.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$324.12B
Close$
$1658.54
14.2% downside
Current Fair Value
14.2% downsideOvervalued by 14.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $324.12 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $16.00 (0.83%) |
| Earnings per Share | $30.24 |
| Beta | 0.19 |
| Outstanding Shares | 166,995,074 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 59.61 |
|---|---|
| PEG | 212.72 |
| Price to Sales | 11.17 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 24, 2026
EPS Estimate
$8.69
Average shareholder expectationRevenue Estimate
$7.58 B
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$10.70
Average shareholder expectationRevenue Estimate
$8.52 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dr. Lal PathLabs Limited
5,206 employees
CEO: Shankha Banerjee Dr. Lal PathLabs Limited runs diagnostic laboratories, performing an extensive range of pathological analyses across India and internationally. The company's comprehensive offerings span various scientific fields such as biochemistry, he...